Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004)-Reference-Cited by-同舟云学术

Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004)

Published:2005-03-07 Issue:2 Volume:23 Page:105-109
ISSN:0914-8779
Container-title:Journal of Bone and Mineral Metabolism
language:en
Short-container-title:J Bone Miner Metab

Author:

Nawata Hajime,Soen Satoshi,Takayanagi Ryoichi,Tanaka Ikuko,Takaoka Kunio,Fukunaga Masao,Matsumoto Toshio,Suzuki Yasuo,Tanaka Hiroyuki,Fujiwara Saeko,Miki Takami,Sagawa Akira,Nishizawa Yoshiki,Seino Yoshiki,

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Orthopedics and Sports Medicine,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s00774-004-0596-x.pdf

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Steroid-Induced Osteoporosis Prevention Using Tracing Reports in Collaboration between Hospitals and Community Pharmacists;Pharmacy;2024-05-15

2. Ten-year fracture risk in Japanese patients with myasthenia gravis: A comprehensive assessment using the fracture risk assessment tool;Journal of the Neurological Sciences;2024-05

3. The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis;Journal of Bone and Mineral Metabolism;2024-03

4. Eupatilin ameliorates postmenopausal osteoporosis via elevating microRNA‐211‐5p and repressing JAK2/STAT3 pathway;Environmental Toxicology;2023-12-21

5. Eupatilin ameliorates postmenopausal osteoporosis via elevating microRNA-211-5p and repressing Janus kinase 2/Signal transducer and activator of transcription 3 pathway;Molecular and Cellular Biochemistry;2023-10-12